South Dakota’s attorney general filed an official explanation of a proposed ballot measure to legalize marijuana on Friday.
While separate organizations are working to get a medical cannabis-focused initiative on the state’s 2020 ballot, activists behind this measure are hoping to incorporate recreational legalization, medical marijuana reform and hemp into one package.
Adult-use legalization would be accomplished through a constitutional amendment under the initiative, which would separately require the legislature to pass legislation creating rules for medical cannabis and hemp.
South Dakota Attorney General releases explanation on proposed constitutional amendment to legalize, regulate, and tax marijuana; to require passage of laws regarding hemp as well as laws regarding marijuana for medical use. Read it here: https://t.co/k33buSKjIJ pic.twitter.com/pEG0RxbDj9
— SD Attorney General (@SDAttorneyGen) August 16, 2019
“The constitutional amendment legalizes the possession, use, transport, and distribution of marijuana and marijuana paraphernalia by people age 21 and older. Individuals may possess or distribute one ounce or less of marijuana,” Attorney General Jason Ravnsborg (R) wrote. “Marijuana plants and marijuana produced from those plants may also be possessed under certain conditions.”
The South Dakota Department of Revenue would be responsible for issuing licenses for cannabis cultivators, manufacturers, testing facilities and retailers. Individual jurisdictions would be able to opt out of allowing such facilities in their areas.
“The Department must enact rules to implement and enforce this amendment,” the explanation states. “The amendment requires the Legislature to pass laws regarding medical use of marijuana. The amendment does not legalize hemp; it requires the Legislature to pass laws regulating the cultivation, processing, and sale of hemp.”
The initiative calls for a 15 percent excise tax on marijuana sales. That revenue would be used to fund the Department of Revenue’s implementation and regulation of the legal cannabis system, with remaining tax dollars going toward public education and the state general fund.
Ravnsborg said that judicial clarification of the amendment “may be necessary” and notes that marijuana “remains illegal under Federal law.”
The attorney general issued a similar explanation of a proposed constitutional amendment to legalize medical cannabis earlier this month.
This latest move comes one day after advocacy organization New Approach South Dakota announced that their medical marijuana initiative was certified, enabling them to begin the signature gathering process.
Several other cannabis initiatives are in the process of being certified in the state, according to the attorney general’s website. In order to place constitutional amendments on the ballot, activists must collect 33,921 valid signatures from voters.
South Dakota is one of the last remaining states in the U.S. that has not legalized marijuana for any purposes.
Photo courtesy of Brian Shamblen.
GOP Congressman Says Marijuana Shops Near Churches Is Evidence Of ‘Spiritual War’
A U.S. congressman said on Saturday that marijuana dispensaries operating on the same streets as churches is “evidence” of the “spiritual war our nation is entrenched in.”
Rep. Doug Lamborn (R-CO) made the comment in a video statement that was presented at an “In God We Trust Rally” organized by the non-profit Truth & Liberty Coalition.
After giving a brief history lesson on the origin of the official U.S. motto and decrying socialism, Lamborn said it was necessary to acknowledge religious strife in the country.
“We need to look no further than our own streets to see evidence of this conflict,” the congressman said. “Marijuana dispensaries are on the same streets as thriving churches.”
Despite representing one of the first states to legalize cannabis, Lamborn has actively worked against the will of Colorado voters who approved the measure in 2012.
For example, he applauded then-Attorney General Jeff Sessions last year after he rescinded Obama-era guidance on federal marijuana enforcement priorities, stating that “legalizing marijuana has been bad for the state of Colorado” and Sessions was “upholding the law and recognizing the serious and proven harms associated with marijuana.”
Every other member of Congress from Colorado signed a bipartisan letter opposing the move.
More recently, Lamborn voted against a spending bill amendment that would prohibit the Justice Department from using funds to enforce prohibition in legal states.
The most that the congressman has said he’s willing to do in terms of cannabis reform is rescheduling the plant to facilitate research into its therapeutic potential. “I’m not sure I could support going beyond that,” he said.
During his video address over the weekend, which was highlighted by Right Wing Watch, Lamborn said evidence of a religious war also includes “abortion clinics” near “pregnancy centers” and legislators attempting to “impose radical gender theory on young students while parents in godly homes teach their children the virtue of marriage.”
“It is easy to despair in the face of ignorance and evil, but today we gather to declare where our trust lies. Our trust lies in god,” he said. “Colorado needs the grace of god more than ever.”
Photo courtesy of YouTube/Truth & Liberty Coalition.
Former White House Drug Czar Offers Marijuana Legalization Advice To Mexico
A former top White House drug official told Mexican officials last week that they will need “robust regulations” in place when the country implements a legal marijuana system.
Gil Kerlikowske, who served as the director of the the Office of National Drug Control Policy under President Barack Obama, made the comments during a panel hosted by the Mexican Senate as part of a series of cannabis conversations lawmakers are holding as the country prepares to enact legalization.
He also acknowledged that state-level legalization in the U.S. has reduced the “appetite” for drugs that are trafficked illegally across the border.
The official’s participation is particularly noteworthy given that he previously said that the word “legalization” was not even in his vocabulary, nor in Obama’s. But according to translated reports of his speech, Kerlikowske, who also served as commissioner of U.S. Customs and Border Protection, now seems decidedly familiar with the concept and offered detailed advice for Mexican lawmakers as they prepare to legalize.
“Tax collection is important because income is used for health and to enforce the law,” he said. “In other words, the marijuana consumer is paying the regulation in taxes, so this is a dynamic and emerging market.”
“I think that frankly, although the taxation can be prohibitive for some people and for some producers, I would say that you still have to have a very robust regulation,” the former drug czar added.
A punto de comenzar la última conferencia del ciclo ‘Rumbo a la regulación del cannabis’, organizado por las comisiones de Justicia, Salud, Estudios Legislativos, Segunda, y Seguridad Pública del @senadomexicano. 🌱 pic.twitter.com/RJxmkieurN
— Cáñamo México (@canamo_mexico) September 13, 2019
Kerlikowske stressed that measures must be taken to ensure that young people don’t have access to marijuana and that policymakers should “do everything possible to eliminate the black market.”
“I believe that governments want to do things slowly—particularly because there is still research being carried out about marijuana and use and the problems it causes in brain formation or decision-making,” he said, adding that alcohol and cannabis shouldn’t be viewed as “benign” products.
He also said that regulating marijuana should involve enforcing labeling and packaging standards so that consumers are fully informed and that steps should be taken to prevent smoking in public.
Sobre permitir fumar cannabis en lugares públicos, Gil Kerlikowske dice que es un tema que se necesita resolver en EU, ya que en lugares como en Seattle el olor es particularmente fuerte. ❔💨❔
— Cáñamo México (@canamo_mexico) September 13, 2019
The event was the last in a five-part “Heading for the Regulation of Cannabis” series that the Senate put together as the chamber’s ruling MORENA party readies legislation to legalize marijuana.
After deeming the prohibition of cannabis possession and cultivation for personal use unconstitutional last year, Mexico’s Supreme Court set a deadline of October 2019 for lawmakers to codify marijuana legalization policy.
Earlier this month, Sen. Julio Menchaca Salazar of the MORENA party filed a bill that would provide for a legal cannabis market for adults by amending federal drug laws.
While legalization is imminent in Mexico, however, Kerlikowske said that he does not believe that the U.S. will legalize within the next two years, stating that the “problem is that medicinal cannabis products have not passed all the tests of the [Food and Drug Administration].”
No creo que en los próximos dos años el Congreso de EU legalice a nivel federal el uso de la marihuana medicinal🌱🔬🧪. El problema es que los productos cannábicos medicinales no han pasados todas las pruebas de la @US_FDA como los demás medicamentos: Gil Kerlikowske 🇺🇸
— Cáñamo México (@canamo_mexico) September 13, 2019
Photo courtesy of Mike Latimer.
Three Federal Agencies Take Public Comments On Cannabis Topics
Three federal agencies—the Food and Drug Administration (FDA), the Environmental Protection Agency (EPA) and the Drug Enforcement Administration (DEA)—are now accepting comments from the public on cannabis-related topics such as hemp pesticides and the legal classification of marijuana globally.
In a notice published in the Federal Register last month, FDA said that it is seeking input on potential changes to the status of marijuana under international treaties.
EPA invited comments on applications for pesticides to be used on hemp, which comes months after the crop was federally legalized.
Meanwhile, people have the chance to share their perspective on a proposal DEA released last week that calls for the cultivation of more than three million grams of cannabis for research purposes next year. That 3.2 million gram quota would be 30 percent higher than this year’s. At the same time, DEA said its quota for prescription painkillers such as fentanyl and oxycodone would be decreased next year by more than 50 percent.
The comment period opened last week, and 25 people have weighed in at this point. Submissions received so far are primarily focused on DEA’s proposed reduction opioid production, with several chronic pain patients arguing that they will be negatively impacted. People can send comments on the cannabis and other drug quotas through October 15.
FDA initially made its request for input on cannabis’s global treaty status in March, but it was closed because an expected United Nations (UN) vote on a proposal to remove marijuana from the most strictly regulated category was postponed.
Last month, FDA said it was reopening the comment period until September 30, in anticipation that the UN will make a decision on the possible changes in the coming months. So far, a total of about 3,000 comments have been received, including those posted since August 29. The vast majority voice support for legalization, with many sharing personal anecdotes about the plant’s therapeutic benefits.
“Please lift the ban and prohibition of marijuana. Marijuana isn’t ruining the lives of countless Americans… America’s drug laws are doing that all by themselves via mass incarceration,” Zach Fowler wrote.
“I am 30 years old and suffer from a progressive neurologically condition that leaves me in constant debilitating pain along with a host of other symptoms. Without cannabis, I could not function enough to work for even care for my children,” Amanda Wood-Devore said. “Cannabis calms my pain, eases corresponding anxiety, and helps my constant nausea and vomiting.”
Alex Rol said that the “current marijuana laws are more destructive than protective.”
“We have seen extensive reports that cannabis can be used for medical purposes and many find its effects increase the ease of life,” he said. “While I understand the concern of those less familiar with cannabis on its legalization it simply isn’t right to incarcerate people for possession of a generally harmless substance.”
“I agree with the [World Health Organization] that cannabis should be removed from the Schedule 1 classification,” Michael Ochipa wrote, referring to a recommendation WHO released in February urging the rescheduling of marijuana and descheduling of CBD.
“Most of the research to date indicates that cannabis has a very positive risk/reward profile,” he wrote. “Side effects are lower, and medicinal benefits are greater than many over the counter drugs. It can also be grown easily at home making it more economical.”
Though it’s not clear how much stock FDA will put into personal stories of individuals who’ve benefited from marijuana in shaping the Trump administration’s position on scheduling changes, the volume of comments and consistency of support for legalization is significant. While there has been a focus on the medical potential of cannabis, several others emphasized the consequences of prohibition, particularly for communities of color.
If the United Nations does decide to adopt WHO’s recommendations, it wouldn’t mean that member nations would be free to legalize marijuana without technically violating the treaties. However, even under its current strict status, Canada and Uruguay have moved forward with legalization models, with Mexico expected to follow suit as early as next month.
Over at EPA, there hasn’t been quite as much interest from the public in submitting comments on pesticides applications for hemp. The agency announced last month that it was accepting input on 10 existing applications and said it hoped “this transparent and public process will bring hemp farmers and researchers increased regulatory clarity in time for next growing season.”
EPA said it’s not required to take public comment on the applications but is doing so “because of the potential significant interest from the public in these initial applications and in furtherance of being completely transparent about these applications.”
There may be significant interest from the public on hemp legalization generally, particularly among stakeholders who are eagerly awaiting federal regulations to unlock the crop’s potential, but that isn’t being reflected on the Federal Register notice page yet when it comes to pesticides. Only five people have commented on the proposal.
One person noted that the 10 pesticides under review contain almost the same ingredients and said “it really limits the ability of producers to manage pests and diseases.”
“I highly recommend expanding the list of compounds available to producers to increase the ability to suppress pests and diseases,” the anonymous commenter wrote. “There are many more bio-pesticides on the market that are safe for humans that specifically target agricultural pests.”
Another individual who said he and his partner are making a transition from growing cannabis in California to hemp in North Carolina wrote in support of the proposed pesticides.
“We have used the products under discussion with great effectiveness, especially the biological controls,” the person said. “Because hemp can be so susceptible to mold, fungus, and pests, it is imperative to have these tools to ensure a healthy and plentiful product.”
Finally, there was one comment in opposition to allowing any pesticides on hemp because, they wrote, “IT WILL JUST TURN IT IN TO POISON.”
EPA’s public comment closes on September 23. The agency did not say when decisions would be made about the applications, but it did state that it planned to give hemp farmers approval to use the tools before the 2020 planting season.
The fact that three separate federal agencies are now accepting comments on separate cannabis issues is another sign that the public has more opportunity than ever before to influence the government’s position on marijuana policy.
Photo courtesy of Nicholas C. Morton.